Fady Hannah-Shmouni, MD FRCPC

Peptides Simplified

Name: Peptides Simplified
Price: 14.99 USD
Availability: InStock
Author: Fady Hannah-Shmouni, MD FRCPC

A modern introduction

$14.99139 pages • PDF • Free sample available

From insulin and GLP-1 agonists to the gray market — a clear-eyed guide to peptide medicine. Peptide medicine is in the middle of its most consequential decade since insulin. Semaglutide and tirzepatide have reshaped how diabetes and obesity are managed, while a parallel market of unapproved compounds — BPC-157, TB-500, CJC-1295, and others — has built up alongside the approved drugs without ever passing through the trials that would justify the claims made for them. This book explains both worlds in language a careful general reader can follow, with every nontrivial claim sourced to a real reference. Five parts cover the chemistry, the approved drug landscape, the GLP-1 revolution, an honest assessment of unapproved peptides, practical pharmacology, safe self-administration of prescribed peptides, and the macroeconomics of the field. By Fady Hannah-Shmouni, MD FRCPC — Clinical Endocrinologist & Geneticist, Founder & CEO of Hormonaly.ai.

About this book

Peptide medicine is having its most consequential decade since insulin was discovered. GLP-1 agonists like semaglutide and tirzepatide have moved peptides from specialist clinics into everyday conversation. With that attention has come a flood of misinformation, gray-market products, and confident claims that outrun the evidence.

Peptides Simplified is a modern introduction for the intelligent non-specialist. It explains what peptides are and how they differ from small-molecule drugs and full proteins. It walks through the peptides that already transformed medicine — insulin, GLP-1 agonists, and their relatives. Then it gives you a framework for evaluating the newer names — recovery peptides, 'longevity' compounds, cosmetic injectables — on the strength of their actual evidence.

Every chapter is written to be readable in one sitting, with the science explained from first principles and the marketing claims tested against the published literature.

What you'll learn

What a peptide actually is — and why the line between peptide, protein, and drug matters for safety and regulation
How insulin became the first therapeutic peptide and what its history teaches about the current boom
How GLP-1 receptor agonists work, what the trial data shows, and what the honest open questions are
A framework for evaluating any peptide claim: mechanism plausibility, evidence tier, and regulatory status
The gray market explained: compounding, research chemicals, and why purity claims deserve skepticism
Which 'longevity' and recovery peptides have real data behind them, and which are running on anecdote

Who it's for

Readers who keep hearing about peptides and want one clear, trustworthy primer
Patients starting (or considering) GLP-1 therapy who want to understand the science
Health professionals outside endocrinology who want a fast, accurate orientation

Frequently asked questions

Do I need a science background to read this?

No. The book is written for the intelligent general reader. Every technical concept is built from first principles, and chapter summaries capture the key points.

Does it cover GLP-1 drugs like Ozempic and Mounjaro?

Yes — the GLP-1 class is covered in depth: how the drugs work, what the major trials showed for weight and metabolic outcomes, side effects, and the questions that remain open.

Is this the same content as the Arabic edition?

The Arabic edition (الببتيدات: مدخل مبسط) is a translation of the same book, adapted for Arabic-speaking readers. The scientific content is identical.